A detailed history of Geode Capital Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,185,525 shares of AXNX stock, worth $82.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,185,525
Previous 1,137,515 4.22%
Holding current value
$82.3 Million
Previous $78.5 Million 1.59%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$66.47 - $69.65 $3.19 Million - $3.34 Million
48,010 Added 4.22%
1,185,525 $79.7 Million
Q1 2024

May 13, 2024

BUY
$56.67 - $69.36 $2.02 Million - $2.47 Million
35,615 Added 3.23%
1,137,515 $78.5 Million
Q4 2023

Feb 13, 2024

BUY
$49.38 - $63.75 $2.98 Million - $3.84 Million
60,308 Added 5.79%
1,101,900 $68.6 Million
Q3 2023

Nov 13, 2023

BUY
$48.64 - $62.51 $1.56 Million - $2.01 Million
32,160 Added 3.19%
1,041,592 $58.5 Million
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $2.28 Million - $2.86 Million
47,546 Added 4.94%
1,009,432 $50.9 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $2.33 Million - $2.98 Million
44,219 Added 4.82%
961,886 $52.5 Million
Q4 2022

Feb 13, 2023

BUY
$59.56 - $76.6 $1.88 Million - $2.41 Million
31,494 Added 3.55%
917,667 $57.4 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $2.93 Million - $3.95 Million
50,620 Added 6.06%
886,173 $62.4 Million
Q2 2022

Aug 12, 2022

BUY
$39.5 - $64.42 $22,080 - $36,010
559 Added 0.07%
835,553 $47.4 Million
Q1 2022

May 13, 2022

BUY
$43.74 - $62.76 $1.3 Million - $1.86 Million
29,682 Added 3.69%
834,994 $52.3 Million
Q4 2021

Feb 11, 2022

BUY
$50.01 - $73.35 $1.17 Million - $1.71 Million
23,347 Added 2.99%
805,312 $45.1 Million
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $7.25 Million - $9.63 Million
122,482 Added 18.57%
781,965 $50.9 Million
Q2 2021

Aug 13, 2021

BUY
$51.39 - $66.9 $6.93 Million - $9.02 Million
134,825 Added 25.7%
659,483 $41.8 Million
Q1 2021

May 12, 2021

BUY
$49.14 - $59.89 $2.44 Million - $2.97 Million
49,562 Added 10.43%
524,658 $31.4 Million
Q4 2020

Feb 12, 2021

BUY
$42.19 - $51.5 $899,997 - $1.1 Million
21,332 Added 4.7%
475,096 $23.7 Million
Q3 2020

Nov 13, 2020

BUY
$35.33 - $51.04 $2.76 Million - $3.99 Million
78,259 Added 20.84%
453,764 $23.2 Million
Q2 2020

Aug 13, 2020

BUY
$22.91 - $39.83 $2.85 Million - $4.95 Million
124,382 Added 49.53%
375,505 $13.2 Million
Q1 2020

May 14, 2020

BUY
$16.44 - $37.73 $672,017 - $1.54 Million
40,877 Added 19.44%
251,123 $6.38 Million
Q4 2019

Feb 13, 2020

BUY
$19.57 - $28.96 $1.06 Million - $1.56 Million
53,951 Added 34.52%
210,246 $5.83 Million
Q3 2019

Nov 12, 2019

BUY
$26.92 - $42.41 $51,121 - $80,536
1,899 Added 1.23%
156,295 $4.21 Million
Q2 2019

Aug 14, 2019

BUY
$18.54 - $40.97 $1.05 Million - $2.33 Million
56,776 Added 58.16%
154,396 $6.33 Million
Q1 2019

May 14, 2019

BUY
$13.32 - $24.35 $299,367 - $547,266
22,475 Added 29.91%
97,620 $2.34 Million
Q4 2018

Feb 13, 2019

BUY
$13.2 - $16.43 $991,914 - $1.23 Million
75,145 New
75,145 $1.14 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.41B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.